首页 > 最新文献

Digital journal of ophthalmology : DJO最新文献

英文 中文
The use of self-retained, cryopreserved amniotic membrane for the treatment of Sjögren syndrome: a case series. 使用自体冷冻羊膜治疗Sjögren综合征:一个病例系列。
Q3 Medicine Pub Date : 2019-01-01 DOI: 10.5693/djo.01.2019.02.005
B. Shafer, Nicole M. Fuerst, M. Massaro‐Giordano, V. Palladino, Taylor Givnish, Ilaria Macchi, M. Sulewski, S. Orlin, V. Bunya
Purpose To determine whether signs and symptoms of ocular surface disease improve after placement of a self-retained, cryopreserved amniotic membrane (CAM) in patients with Sjögren syndrome (SS). Methods The medical records of SS patients who received a self-retained CAM implant (Prokera or Prokera Slim; TissueTech Inc, Doral, FL) for the treatment of ocular surface disease between August 2012 and August 2016 at a single, large academic institution were reviewed retrospectively. Visual acuity, results of slit-lamp examination of the cornea and conjunctiva, and dry eye symptoms, were evaluated before and after CAM insertion. Results A total of 6 eyes of 6 patients (all female; mean age, 62.5 ± 13.0 years [range, 49-86 years]) were included. All patients were on topical medications at the time of the study and had signs of ocular surface dryness. There were reductions in corneal and/or conjunctival staining in 5 eyes (83%) after the CAM dissolved. All patients who completed therapy (5/5) experienced a relapse in their signs and symptoms within 1 month of removal of the CAM, with an average time to relapse of 24.6 days. Mean follow-up time was 54.5 days. Foreign body sensation and blurred vision were the most common complaints associated with the CAM implant. Conclusions In this small case series, self-retained CAM implantation was found to be beneficial in SS patients with ocular surface disease that is refractory to standard therapies; however, we found that the effects were temporary. Future larger studies are needed to confirm these benefits.
目的探讨Sjögren综合征(SS)患者置放自体冷冻羊膜(CAM)后眼表疾病的体征和症状是否得到改善。方法对SS患者采用自保留CAM种植体(Prokera或Prokera Slim;回顾性回顾了2012年8月至2016年8月在一家大型学术机构进行的TissueTech Inc ., Doral, FL)治疗眼表疾病的研究。观察植入CAM前后的视力、角膜和结膜的裂隙灯检查结果以及干眼症状。结果6例患者共6眼(均为女性;平均年龄62.5±13.0岁(范围49 ~ 86岁)。所有患者在研究时都在服用局部药物,并有眼表干燥的迹象。CAM溶解后,有5只眼(83%)的角膜和/或结膜染色减少。所有完成治疗的患者(5/5)在移除CAM后1个月内出现症状和体征复发,平均复发时间为24.6天。平均随访时间54.5天。异物感和视力模糊是与CAM植入物相关的最常见的抱怨。结论在这个小病例系列中,发现自体保留CAM植入对伴有标准治疗难治性眼表疾病的SS患者是有益的;然而,我们发现这些影响是暂时的。未来需要更大规模的研究来证实这些益处。
{"title":"The use of self-retained, cryopreserved amniotic membrane for the treatment of Sjögren syndrome: a case series.","authors":"B. Shafer, Nicole M. Fuerst, M. Massaro‐Giordano, V. Palladino, Taylor Givnish, Ilaria Macchi, M. Sulewski, S. Orlin, V. Bunya","doi":"10.5693/djo.01.2019.02.005","DOIUrl":"https://doi.org/10.5693/djo.01.2019.02.005","url":null,"abstract":"Purpose To determine whether signs and symptoms of ocular surface disease improve after placement of a self-retained, cryopreserved amniotic membrane (CAM) in patients with Sjögren syndrome (SS). Methods The medical records of SS patients who received a self-retained CAM implant (Prokera or Prokera Slim; TissueTech Inc, Doral, FL) for the treatment of ocular surface disease between August 2012 and August 2016 at a single, large academic institution were reviewed retrospectively. Visual acuity, results of slit-lamp examination of the cornea and conjunctiva, and dry eye symptoms, were evaluated before and after CAM insertion. Results A total of 6 eyes of 6 patients (all female; mean age, 62.5 ± 13.0 years [range, 49-86 years]) were included. All patients were on topical medications at the time of the study and had signs of ocular surface dryness. There were reductions in corneal and/or conjunctival staining in 5 eyes (83%) after the CAM dissolved. All patients who completed therapy (5/5) experienced a relapse in their signs and symptoms within 1 month of removal of the CAM, with an average time to relapse of 24.6 days. Mean follow-up time was 54.5 days. Foreign body sensation and blurred vision were the most common complaints associated with the CAM implant. Conclusions In this small case series, self-retained CAM implantation was found to be beneficial in SS patients with ocular surface disease that is refractory to standard therapies; however, we found that the effects were temporary. Future larger studies are needed to confirm these benefits.","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"23 1","pages":"21-25"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83978440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
A 51-year-old woman with binocular diplopia and unilateral ptosis. 女性,51岁,双眼复视,单侧上睑下垂。
Q3 Medicine Pub Date : 2019-01-01 DOI: 10.5693/djo.03.2019.07.001
Landon J. Rohowetz, Anjulie K Quick
{"title":"A 51-year-old woman with binocular diplopia and unilateral ptosis.","authors":"Landon J. Rohowetz, Anjulie K Quick","doi":"10.5693/djo.03.2019.07.001","DOIUrl":"https://doi.org/10.5693/djo.03.2019.07.001","url":null,"abstract":"","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"1 1","pages":"41-44"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85114060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cogan-Reese syndrome: image analysis with specular microscopy, optical coherence tomography, and ultrasound biomicroscopy. Cogan-Reese综合征:用镜面显微镜、光学相干断层扫描和超声生物显微镜进行图像分析。
Q3 Medicine Pub Date : 2019-01-01 DOI: 10.5693/djo.02.2019.05.001
Denise Loya-García, J. Hernández-Camarena, J. Valdez-García, A. Rodríguez-Garcia
Iridocorneal endothelial (ICE) syndrome is a progressive clinical spectrum of corneal endothelial abnormalities affecting the cornea, iris, and iridocorneal angle. Three clinical variations are recognized: essential (progressive) iris atrophy, Chandler syndrome, and Cogan-Reese syndrome. Direct slit-lamp visualization of the cornea and anterior segment in cases of ICE syndrome is inadequate for precise and objective assessment of the affected structures. We describe the evolution of corneal and anterior segment structural changes in a woman with Cogan-Reese syndrome using three different methods of image analysis: specular microscopy, anterior segment optical coherence tomography, and ultrasound biomicroscopy.
虹膜角膜内皮(ICE)综合征是一种影响角膜、虹膜和虹膜角的进行性角膜内皮异常的临床表现。三种临床变异是公认的:原发性(进行性)虹膜萎缩,钱德勒综合征和Cogan-Reese综合征。在ICE综合征的病例中,直接用裂隙灯观察角膜和前段不足以精确和客观地评估受影响的结构。我们用三种不同的图像分析方法描述了Cogan-Reese综合征女性角膜和前段结构变化的演变:反射显微镜、前段光学相干断层扫描和超声生物显微镜。
{"title":"Cogan-Reese syndrome: image analysis with specular microscopy, optical coherence tomography, and ultrasound biomicroscopy.","authors":"Denise Loya-García, J. Hernández-Camarena, J. Valdez-García, A. Rodríguez-Garcia","doi":"10.5693/djo.02.2019.05.001","DOIUrl":"https://doi.org/10.5693/djo.02.2019.05.001","url":null,"abstract":"Iridocorneal endothelial (ICE) syndrome is a progressive clinical spectrum of corneal endothelial abnormalities affecting the cornea, iris, and iridocorneal angle. Three clinical variations are recognized: essential (progressive) iris atrophy, Chandler syndrome, and Cogan-Reese syndrome. Direct slit-lamp visualization of the cornea and anterior segment in cases of ICE syndrome is inadequate for precise and objective assessment of the affected structures. We describe the evolution of corneal and anterior segment structural changes in a woman with Cogan-Reese syndrome using three different methods of image analysis: specular microscopy, anterior segment optical coherence tomography, and ultrasound biomicroscopy.","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"66 1","pages":"26-29"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76563874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Orbital desmoplastic small round cell tumor in an infant. 婴儿眼眶结缔组织增生小圆细胞瘤。
Q3 Medicine Pub Date : 2018-12-31 eCollection Date: 2018-01-01 DOI: 10.5693/djo.02.2018.10.001
Amy Huang, Nishita Patel

Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive malignancy that primarily involves the serosal surfaces of the abdomen and pelvis and has a poor prognosis. Orbital involvement is extremely rare. We report the case of a 2-month-old boy who presented with a right infraorbital mass consistent with a DSRCT and causing mass effect and superonasal globe displacement. To our knowledge, this is the first case of orbital DSRCT in an infant.

结缔组织增生小圆细胞瘤(DSRCT)是一种罕见的侵袭性恶性肿瘤,主要累及腹部和骨盆浆膜表面,预后较差。眼眶受累极为罕见。我们报告了一个2个月大的男孩,他表现出与DSRCT一致的右眶下肿块,并导致肿块效应和鼻上球体移位。据我们所知,这是婴儿眼眶DSRCT的第一例。
{"title":"Orbital desmoplastic small round cell tumor in an infant.","authors":"Amy Huang,&nbsp;Nishita Patel","doi":"10.5693/djo.02.2018.10.001","DOIUrl":"https://doi.org/10.5693/djo.02.2018.10.001","url":null,"abstract":"<p><p>Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive malignancy that primarily involves the serosal surfaces of the abdomen and pelvis and has a poor prognosis. Orbital involvement is extremely rare. We report the case of a 2-month-old boy who presented with a right infraorbital mass consistent with a DSRCT and causing mass effect and superonasal globe displacement. To our knowledge, this is the first case of orbital DSRCT in an infant.</p>","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"24 4","pages":"31-35"},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380253/pdf/djo-18-038.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37169587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Povidone-iodine concentration and in vitro killing time of bacterial corneal ulcer isolates. 聚维酮-碘对细菌性角膜溃疡分离株体外杀伤时间的影响。
Q3 Medicine Pub Date : 2018-12-19 eCollection Date: 2018-01-01 DOI: 10.5693/djo.01.2018.06.001
Jagger C Koerner, Mary J George, Elizabeth A Kissam, Michael G Rosco

Background: The concentration and dosing of povidone-iodine (PI) solution used in surgical site prophylaxis are variable. Prior in vitro work has demonstrated that dilute PI solutions (<1%) had greater bactericidal activity than stock solutions (10%). Studies using pathologic clinical isolates from the eye have yielded mixed results. The purpose of the current study was to evaluate the efficacy of different concentrations of PI on pathologic ocular surface isolates.

Methods: We conducted an in vitro microbiology study using clinical isolates from corneal ulcers. Bacteria were recovered from trypticase soy agar with 5% sheep erythrocytes, chocolate agar, and thioglycollate broth media. A standardized concentration of each bacterial sample (1 × 108 cfu/ml) was exposed to various dilutions of PI. Quantitative cultures were performed to determine the number of organisms surviving PI exposure.

Results: None of the isolates survived exposure to the PI 0.25% solution for 30 seconds. Micrococcus luteus and Staphylococcus aureus survived both 30-second and 1-minute exposure to PI 5% and 10%. The exposure time required to produce no growth was variable with concentrations of <0.25%. In some isolates, the 10% solution was faster than the more dilute solutions (0.1%, 0.05%).

Conclusions: Our results are consistent with prior in vitro studies of PI, from nonocular sources, and suggest that PI has similar bactericidal action on pathologic bacteria from the ocular surface. In vitro exposure to dilute PI (0.25%) resulted in no growth after 30 seconds, whereas 10% and 5% solutions took longer to kill several of the isolates. Future investigations of PI use in ophthalmology as an antimicrobial agent should include the study of low-concentration PI (0.25%).

背景:聚维酮碘(PI)溶液用于手术部位预防的浓度和剂量是可变的。先前的体外研究表明,稀释PI溶液(方法:我们使用角膜溃疡的临床分离物进行了体外微生物学研究。用5%绵羊红细胞、巧克力琼脂和巯基乙酸盐肉汤培养基从胰酶大豆琼脂中回收细菌。每个细菌样本的标准浓度(1 × 108 cfu/ml)暴露于不同稀释度的PI。进行定量培养以确定暴露于PI后存活的生物体数量。结果:暴露于PI 0.25%溶液30秒后,所有分离株均未存活。黄体微球菌和金黄色葡萄球菌在暴露于PI的30秒和1分钟内均存活5%和10%。结论:我们的结果与之前的非眼源PI体外研究一致,并表明PI对眼表面的病理细菌具有类似的杀菌作用。在体外暴露于稀释的PI(0.25%) 30秒后没有生长,而10%和5%的溶液需要更长的时间才能杀死几个分离株。今后在眼科应用PI作为抗菌药物的研究应包括低浓度PI(0.25%)的研究。
{"title":"Povidone-iodine concentration and in vitro killing time of bacterial corneal ulcer isolates.","authors":"Jagger C Koerner,&nbsp;Mary J George,&nbsp;Elizabeth A Kissam,&nbsp;Michael G Rosco","doi":"10.5693/djo.01.2018.06.001","DOIUrl":"https://doi.org/10.5693/djo.01.2018.06.001","url":null,"abstract":"<p><strong>Background: </strong>The concentration and dosing of povidone-iodine (PI) solution used in surgical site prophylaxis are variable. Prior in vitro work has demonstrated that dilute PI solutions (<1%) had greater bactericidal activity than stock solutions (10%). Studies using pathologic clinical isolates from the eye have yielded mixed results. The purpose of the current study was to evaluate the efficacy of different concentrations of PI on pathologic ocular surface isolates.</p><p><strong>Methods: </strong>We conducted an in vitro microbiology study using clinical isolates from corneal ulcers. Bacteria were recovered from trypticase soy agar with 5% sheep erythrocytes, chocolate agar, and thioglycollate broth media. A standardized concentration of each bacterial sample (1 × 10<sup>8</sup> cfu/ml) was exposed to various dilutions of PI. Quantitative cultures were performed to determine the number of organisms surviving PI exposure.</p><p><strong>Results: </strong>None of the isolates survived exposure to the PI 0.25% solution for 30 seconds. <i>Micrococcus luteus</i> and <i>Staphylococcus aureus</i> survived both 30-second and 1-minute exposure to PI 5% and 10%. The exposure time required to produce no growth was variable with concentrations of <0.25%. In some isolates, the 10% solution was faster than the more dilute solutions (0.1%, 0.05%).</p><p><strong>Conclusions: </strong>Our results are consistent with prior in vitro studies of PI, from nonocular sources, and suggest that PI has similar bactericidal action on pathologic bacteria from the ocular surface. In vitro exposure to dilute PI (0.25%) resulted in no growth after 30 seconds, whereas 10% and 5% solutions took longer to kill several of the isolates. Future investigations of PI use in ophthalmology as an antimicrobial agent should include the study of low-concentration PI (0.25%).</p>","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"24 4","pages":"24-26"},"PeriodicalIF":0.0,"publicationDate":"2018-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380258/pdf/djo-18-039.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37169585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Iris melanin pigment as a masquerade of Gram-positive cocci after penetrating ocular trauma. 穿透性眼外伤后虹膜黑色素作为革兰氏阳性球菌的伪装物。
Q3 Medicine Pub Date : 2018-10-18 eCollection Date: 2018-01-01 DOI: 10.5693/djo.02.2018.07.002
Wenlan Zhang, Alan D Proia, Sumit Sharma, David Fleischman

We describe a case of penetrating eye injury that resulted in a post-injury day 1 hypopyon, leading to concern for endophthalmitis and phacoanaphylaxis. A Gram stain prepared by the clinical microbiology laboratory was interpreted as Gram-positive cocci (GPC). However, when cultures returned negative, further investigation with microbiology and pathology found that what was thought to be GPC was actually iris melanin pigment. Although endophthalmitis following ocular trauma remains an important diagnosis to consider, this microbiologic masquerade of iris melanin pigment as GPC should be considered in cases where Gram stain is positive yet cultures return negative.

我们描述了一个病例的穿透性眼损伤,导致损伤后的第1天hypyon,导致关注眼内炎和过敏反应。临床微生物实验室革兰氏染色为革兰氏阳性球菌(GPC)。然而,当培养结果为阴性时,进一步的微生物学和病理学调查发现,被认为是GPC的东西实际上是虹膜黑色素。虽然眼外伤后的眼内炎仍然是一个需要考虑的重要诊断,但在革兰氏染色阳性但培养结果阴性的情况下,应考虑虹膜黑色素作为GPC的微生物伪装。
{"title":"Iris melanin pigment as a masquerade of Gram-positive cocci after penetrating ocular trauma.","authors":"Wenlan Zhang,&nbsp;Alan D Proia,&nbsp;Sumit Sharma,&nbsp;David Fleischman","doi":"10.5693/djo.02.2018.07.002","DOIUrl":"https://doi.org/10.5693/djo.02.2018.07.002","url":null,"abstract":"<p><p>We describe a case of penetrating eye injury that resulted in a post-injury day 1 hypopyon, leading to concern for endophthalmitis and phacoanaphylaxis. A Gram stain prepared by the clinical microbiology laboratory was interpreted as Gram-positive cocci (GPC). However, when cultures returned negative, further investigation with microbiology and pathology found that what was thought to be GPC was actually iris melanin pigment. Although endophthalmitis following ocular trauma remains an important diagnosis to consider, this microbiologic masquerade of iris melanin pigment as GPC should be considered in cases where Gram stain is positive yet cultures return negative.</p>","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"24 4","pages":"27-30"},"PeriodicalIF":0.0,"publicationDate":"2018-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380259/pdf/djo-18-028.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37169586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient attitudes toward novel glaucoma drug delivery approaches. 患者对新型青光眼药物给药途径的态度。
Q3 Medicine Pub Date : 2018-09-30 eCollection Date: 2018-01-01 DOI: 10.5693/djo.01.2018.07.001
Benjamin B Wang, Michael M Lin, Thuan Nguyen, Angela V Turalba

Purpose: Understanding patients' attitudes toward novel therapeutic options can help guide providers in personalizing treatment regimens for glaucoma patients. This study aimed to determine factors associated with acceptance of new drug delivery options among glaucoma patients.

Methods: A total of 199 patient volunteers participated in an interviewer-administered survey from June to August 2016 at the Glaucoma Service of Massachusetts Eye and Ear. The questionnaire was designed to determine acceptance of 6 drug delivery approaches: (1) triple combination eye drop, (2) microdose eye spray, (3) drug-eluting contact lens, (4) drug-eluting periocular ring insert, (5) injectable subconjunctival drug insert, and (6) injectable anterior chamber implant. Other factors analyzed included self-reported demographics, disease severity, and prior ocular history.

Results: The average respondent age was 63.2 ± 15.1 years; 48% were female. For approaches 1-6 listed above, overall acceptance rates were, respectively, 85%, 54%, 31%, 43%, 32%, and 30%. Patients with greater disease severity and prior incisional glaucoma surgery were more likely to pursue alternatives to traditional eye drops.

Conclusions: There is limited acceptance of alternatives to traditional eye drop medications among glaucoma patients. Understanding motivating factors and potential barriers to patient acceptance of novel drug delivery approaches is important in how providers will incorporate these glaucoma treatment options into practice.

目的:了解患者对新型治疗方案的态度,有助于指导青光眼患者的个性化治疗方案。本研究旨在确定青光眼患者接受新给药方案的相关因素。方法:2016年6月至8月,共有199名患者志愿者参加了马萨诸塞州眼耳青光眼服务中心的访谈式调查。问卷旨在确定6种给药方式的接受度:(1)三联滴眼液,(2)微剂量眼喷雾剂,(3)药物洗脱隐形眼镜,(4)药物洗脱眼周植入物,(5)可注射结膜下药物植入物,(6)可注射前房植入物。分析的其他因素包括自我报告的人口统计学、疾病严重程度和既往眼部病史。结果:平均年龄63.2±15.1岁;48%是女性。对于上述方法1-6,总体接受率分别为85%、54%、31%、43%、32%和30%。病情严重且既往有切口青光眼手术的患者更有可能寻求替代传统滴眼液。结论:青光眼患者对替代传统滴眼液药物的接受程度有限。了解患者接受新药物给药方法的激励因素和潜在障碍对于提供者如何将这些青光眼治疗方案纳入实践非常重要。
{"title":"Patient attitudes toward novel glaucoma drug delivery approaches.","authors":"Benjamin B Wang,&nbsp;Michael M Lin,&nbsp;Thuan Nguyen,&nbsp;Angela V Turalba","doi":"10.5693/djo.01.2018.07.001","DOIUrl":"https://doi.org/10.5693/djo.01.2018.07.001","url":null,"abstract":"<p><strong>Purpose: </strong>Understanding patients' attitudes toward novel therapeutic options can help guide providers in personalizing treatment regimens for glaucoma patients. This study aimed to determine factors associated with acceptance of new drug delivery options among glaucoma patients.</p><p><strong>Methods: </strong>A total of 199 patient volunteers participated in an interviewer-administered survey from June to August 2016 at the Glaucoma Service of Massachusetts Eye and Ear. The questionnaire was designed to determine acceptance of 6 drug delivery approaches: (1) triple combination eye drop, (2) microdose eye spray, (3) drug-eluting contact lens, (4) drug-eluting periocular ring insert, (5) injectable subconjunctival drug insert, and (6) injectable anterior chamber implant. Other factors analyzed included self-reported demographics, disease severity, and prior ocular history.</p><p><strong>Results: </strong>The average respondent age was 63.2 ± 15.1 years; 48% were female. For approaches 1-6 listed above, overall acceptance rates were, respectively, 85%, 54%, 31%, 43%, 32%, and 30%. Patients with greater disease severity and prior incisional glaucoma surgery were more likely to pursue alternatives to traditional eye drops.</p><p><strong>Conclusions: </strong>There is limited acceptance of alternatives to traditional eye drop medications among glaucoma patients. Understanding motivating factors and potential barriers to patient acceptance of novel drug delivery approaches is important in how providers will incorporate these glaucoma treatment options into practice.</p>","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"24 2","pages":"16-23"},"PeriodicalIF":0.0,"publicationDate":"2018-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380257/pdf/djo-18-031.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37169584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Self-inflicted injection of tattoo ink in the anterior chamber: a failed attempt to change the color of the eyes. 自己在前房注射了纹身墨水试图改变眼睛的颜色失败了。
Q3 Medicine Pub Date : 2018-06-30 eCollection Date: 2018-01-01 DOI: 10.5693/djo.02.2018.01.002
José D Paulo, Juan Carlos Mejía Turizo, Diana Carolina Montoya Carrasquilla, Luisa Maria Bustamante

We report the case of a 29-year-old man, a tattoo artist by profession, with a history of schizophrenia, who was admitted to our hospital after injecting tattoo pigments in the anterior chamber of both eyes using a dermograph. The patient was diagnosed with penetrating ocular injury with secondary glaucoma, endotheliitis, and uveitis. Anterior chamber washout was performed immediately. At 4 months' follow-up the patient had a visual acuity of 20/25 in each eye and 360° peripheral anterior synechiae; there still were traces of tattoo pigment at the trabecular meshwork and endothelial corneal layer.

我们报告一例29岁的男性,职业纹身师,有精神分裂症病史,他在使用皮肤涂片在双眼前房注射纹身色素后入院。患者被诊断为穿透性眼损伤并发继发性青光眼、内皮炎和葡萄膜炎。立即进行前房冲洗。随访4个月,患者每眼视力为20/25,周围前粘连360°;在小梁网和角膜内皮层仍有纹身色素的痕迹。
{"title":"Self-inflicted injection of tattoo ink in the anterior chamber: a failed attempt to change the color of the eyes.","authors":"José D Paulo,&nbsp;Juan Carlos Mejía Turizo,&nbsp;Diana Carolina Montoya Carrasquilla,&nbsp;Luisa Maria Bustamante","doi":"10.5693/djo.02.2018.01.002","DOIUrl":"https://doi.org/10.5693/djo.02.2018.01.002","url":null,"abstract":"<p><p>We report the case of a 29-year-old man, a tattoo artist by profession, with a history of schizophrenia, who was admitted to our hospital after injecting tattoo pigments in the anterior chamber of both eyes using a dermograph. The patient was diagnosed with penetrating ocular injury with secondary glaucoma, endotheliitis, and uveitis. Anterior chamber washout was performed immediately. At 4 months' follow-up the patient had a visual acuity of 20/25 in each eye and 360° peripheral anterior synechiae; there still were traces of tattoo pigment at the trabecular meshwork and endothelial corneal layer.</p>","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"24 3","pages":"10-12"},"PeriodicalIF":0.0,"publicationDate":"2018-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380255/pdf/djo-17-071.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37155546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Bilateral uveal effusions in a 23-year-old man. 23岁男性双侧葡萄膜积液。
Q3 Medicine Pub Date : 2018-05-22 eCollection Date: 2018-01-01 DOI: 10.5693/djo.03.2018.03.001
Karen W Jeng-Miller, Eric D Gaier, Angela V Turalba
A 23-year-old white man with a past medical history of seasonal allergies and no prior ocular history presented emergently to the Massachusetts Eye and Ear Emergency Ward with acute, bilateral blurry vision of one day’s duration that had worsened overnight. He reported epiphora in both eyes and head pressure without headache. He described intermittent scintillations in both eyes of white and blue color. The patient reported taking a single dose of a “muscle relaxer” 10 days prior; he was unsure of the name of the drug. He denied any other new medications. He also reported an isolated episode of diarrhea on the day his blurry vision started. He denied eye pain, floaters, trauma, diplopia, fevers, rashes, recent travel, insect bites, myalgias, joint pain, dysuria, hematuria, melena, hematochezia, or shortness of breath. He cited occasional marijuana usage but no other recreational drug use.
{"title":"Bilateral uveal effusions in a 23-year-old man.","authors":"Karen W Jeng-Miller,&nbsp;Eric D Gaier,&nbsp;Angela V Turalba","doi":"10.5693/djo.03.2018.03.001","DOIUrl":"https://doi.org/10.5693/djo.03.2018.03.001","url":null,"abstract":"A 23-year-old white man with a past medical history of seasonal allergies and no prior ocular history presented emergently to the Massachusetts Eye and Ear Emergency Ward with acute, bilateral blurry vision of one day’s duration that had worsened overnight. He reported epiphora in both eyes and head pressure without headache. He described intermittent scintillations in both eyes of white and blue color. The patient reported taking a single dose of a “muscle relaxer” 10 days prior; he was unsure of the name of the drug. He denied any other new medications. He also reported an isolated episode of diarrhea on the day his blurry vision started. He denied eye pain, floaters, trauma, diplopia, fevers, rashes, recent travel, insect bites, myalgias, joint pain, dysuria, hematuria, melena, hematochezia, or shortness of breath. He cited occasional marijuana usage but no other recreational drug use.","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"24 3","pages":"13-15"},"PeriodicalIF":0.0,"publicationDate":"2018-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380252/pdf/djo-17-132.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37169589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of inhaled steroids on the intraocular pressure. 吸入类固醇对眼压的影响。
Q3 Medicine Pub Date : 2018-05-12 eCollection Date: 2018-01-01 DOI: 10.5693/djo.01.2018.04.001
Sujani Shroff, Reji Koshy Thomas, George D'Souza, Suneetha Nithyanandan

Background: Steroids are known to play a role in the pathogenesis of glaucoma, but little is known about the effect of inhaled corticosteroids (ICS). The purpose of this study was to investigate whether there is a clinically significant association between inhalational steroids and intraocular pressure (IOP).

Methods: This was a cross-sectional, case-control study performed at St John's Medical College, Bengaluru, India, from October 2013 to July 2015 of 200 patients using 800 mcg of budesonide or its equivalent dose of ICS and 200 healthy controls not using any form of steroids. Patients using ICS for a period of at least 6 months with no usage of oral or topical steroids within the last 3 months were included as cases. Age- and sex-matched controls were recruited from among the general patient population of the ophthalmological department. IOP and central corneal thickness (CCT) were analyzed. Cases were divided into two subgroups. Group 1 had IOP of <21 mm Hg and cup-to-disc ratio of <0.5. Group 2 had IOP of ≥21 mm Hg or cup-to-disc ratio of ≥0.5 or cup-disc asymmetry ≥0.2. These two subgroups were analyzed to determine whether there was an increased risk of developing ocular hypertension or glaucoma with extended use of ICS.

Results: A total of 400 subjects participated, with 200 in each group. The mean IOP of cases was 15.31 ± 3.27 mm Hg, statistically significantly higher than the mean of 13.39 mm Hg ± 1.95 in controls (P < 0.001). The mean CCT in cases was 522.02 ± 30.47 μm, lower than the mean of 528.73 ± 29.09 μm of the control group (P > 0.001). Of the 200 cases, 11 (5.5%) had ocular hypertension and 2 (1%) had open-angle glaucoma. There was no statistically significant correlation between duration of inhaled steroids usage and increase in IOP (P = 0.62). There was no development of ocular hypertension or glaucoma among the controls.

Conclusions: Our findings suggest a probable association between ICS and IOP and that it may be advisable to measure baseline IOPs and CCT and to follow patients on ICS at regular intervals.

背景:已知类固醇在青光眼的发病机制中起作用,但对吸入皮质类固醇(ICS)的作用知之甚少。本研究的目的是探讨吸入类固醇与眼内压(IOP)之间是否存在临床意义上的关联。方法:这是一项横断面病例对照研究,于2013年10月至2015年7月在印度班加罗尔圣约翰医学院进行,200名患者使用800 mcg布地奈德或其等效剂量的ICS, 200名健康对照组不使用任何形式的类固醇。使用ICS至少6个月且在过去3个月内未使用口服或局部类固醇的患者被纳入病例。年龄和性别匹配的对照组从眼科的一般患者人群中招募。分析眼压和角膜中央厚度(CCT)。病例分为两个亚组。结果:共400例受试者参加,每组200例。患者平均IOP为15.31±3.27 mm Hg,高于对照组13.39 mm Hg±1.95,差异有统计学意义(P < 0.001)。病例CCT平均值为522.02±30.47 μm,低于对照组的平均值528.73±29.09 μm (P > 0.001)。200例患者中,高眼压11例(5.5%),开角型青光眼2例(1%)。吸入类固醇使用时间与IOP升高之间无统计学意义的相关性(P = 0.62)。对照组中没有发生高眼压或青光眼。结论:我们的研究结果表明ICS和IOP之间可能存在关联,建议测量基线IOPs和CCT,并定期随访ICS患者。
{"title":"The effect of inhaled steroids on the intraocular pressure.","authors":"Sujani Shroff,&nbsp;Reji Koshy Thomas,&nbsp;George D'Souza,&nbsp;Suneetha Nithyanandan","doi":"10.5693/djo.01.2018.04.001","DOIUrl":"https://doi.org/10.5693/djo.01.2018.04.001","url":null,"abstract":"<p><strong>Background: </strong>Steroids are known to play a role in the pathogenesis of glaucoma, but little is known about the effect of inhaled corticosteroids (ICS). The purpose of this study was to investigate whether there is a clinically significant association between inhalational steroids and intraocular pressure (IOP).</p><p><strong>Methods: </strong>This was a cross-sectional, case-control study performed at St John's Medical College, Bengaluru, India, from October 2013 to July 2015 of 200 patients using 800 mcg of budesonide or its equivalent dose of ICS and 200 healthy controls not using any form of steroids. Patients using ICS for a period of at least 6 months with no usage of oral or topical steroids within the last 3 months were included as cases. Age- and sex-matched controls were recruited from among the general patient population of the ophthalmological department. IOP and central corneal thickness (CCT) were analyzed. Cases were divided into two subgroups. Group 1 had IOP of <21 mm Hg and cup-to-disc ratio of <0.5. Group 2 had IOP of ≥21 mm Hg or cup-to-disc ratio of ≥0.5 or cup-disc asymmetry ≥0.2. These two subgroups were analyzed to determine whether there was an increased risk of developing ocular hypertension or glaucoma with extended use of ICS.</p><p><strong>Results: </strong>A total of 400 subjects participated, with 200 in each group. The mean IOP of cases was 15.31 ± 3.27 mm Hg, statistically significantly higher than the mean of 13.39 mm Hg ± 1.95 in controls (<i>P</i> < 0.001). The mean CCT in cases was 522.02 ± 30.47 μm, lower than the mean of 528.73 ± 29.09 μm of the control group (<i>P</i> > 0.001). Of the 200 cases, 11 (5.5%) had ocular hypertension and 2 (1%) had open-angle glaucoma. There was no statistically significant correlation between duration of inhaled steroids usage and increase in IOP (<i>P</i> = 0.62). There was no development of ocular hypertension or glaucoma among the controls.</p><p><strong>Conclusions: </strong>Our findings suggest a probable association between ICS and IOP and that it may be advisable to measure baseline IOPs and CCT and to follow patients on ICS at regular intervals.</p>","PeriodicalId":38112,"journal":{"name":"Digital journal of ophthalmology : DJO","volume":"24 3","pages":"6-9"},"PeriodicalIF":0.0,"publicationDate":"2018-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5693/djo.01.2018.04.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37155545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
期刊
Digital journal of ophthalmology : DJO
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1